Gain Therapeutics, Inc. (GANX) Ownership

$1.68

$0 (0.26%)
Last update: 10:30 AM EST
Day's range
$1.66
Day's range
$1.69

Gain Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
DME CAPITAL MANAGEMENT, LP 05/15/2025 566.13 K $1.08 M   0.00% 1.97%
JONES FINANCIAL COMPANIES LLLP 05/28/2025 427.70 K $808.35 K   335.32% 1.49%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 282.21 K $539.09 K   5.53% 0.98%
VANGUARD GROUP INC 05/09/2025 254.99 K $487.03 K   44.00% 0.89%
MARSHALL WACE, LLP 05/15/2025 196.03 K $374.41 K   113.68% 0.68%
GOTHAM ASSET MANAGEMENT, LLC 05/15/2025 153.98 K $3.17 M   -2.64% 0.54%
05/07/2025 125.58 K $239.87 K   100.00% 0.44%
NORTHERN TRUST CORP 05/13/2025 100.17 K $191.33 K   18.42% 0.35%
MORGAN STANLEY 05/15/2025 99.80 K $190.61 K   12.75% 0.35%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 85.96 K $164.18 K   83.23% 0.30%
BLACKROCK, INC. 05/02/2025 84.41 K $161.22 K   -1.92% 0.29%
STATE STREET CORP 05/15/2025 71.14 K $135.87 K   0.00% 0.25%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 04/22/2025 59.50 K $114.00 K   9.17% 0.21%
KOVITZ INVESTMENT GROUP PARTNERS, LLC 05/19/2025 47.58 K $90.87 K   100.00% 0.17%
UBS GROUP AG 05/13/2025 43.36 K $82.82 K   23.09% 0.15%
PRELUDE CAPITAL MANAGEMENT, LLC 05/15/2025 35.82 K $68.42 K   0.00% 0.12%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2025 30.00 K $57.31 K   0.00% 0.10%
QUADRATURE CAPITAL LTD 05/13/2025 20.15 K $38.29 K   100.00% 0.07%
CITADEL ADVISORS LLC 05/15/2025 19.02 K $36.33 K   63.79% 0.07%
BENEDICT FINANCIAL ADVISORS INC 05/07/2025 18.00 K $34.38 K   12.50% 0.06%
SANDHILL CAPITAL PARTNERS LLC 05/14/2025 15.40 K $29.41 K   0.00% 0.05%
TWO SIGMA SECURITIES, LLC 05/15/2025 14.36 K $27.42 K   100.00% 0.05%
SPROTT INC. 05/14/2025 14.00 K $26.74 K   0.00% 0.05%
05/08/2025 10.75 K $22.04 K   100.00% 0.04%
NEWEDGE ADVISORS, LLC 05/15/2025 10.60 K $20.25 K   100.00% 0.04%
CITADEL ADVISORS LLC 05/15/2025 8.70 K $16.62 K   -17.92% 0.03%
CITADEL ADVISORS LLC 05/15/2025 8.40 K $16.04 K   47.37% 0.03%
CREEKMUR ASSET MANAGEMENT LLC 05/05/2025 4.44 K $8.48 K   0.00% 0.02%
MAI CAPITAL MANAGEMENT 05/15/2025 4.41 K $8.42 K   0.00% 0.02%
BANK OF AMERICA CORP /DE/ 05/15/2025 4.10 K $7.84 K   0.42% 0.01%
SIMPLEX TRADING, LLC 05/12/2025 3.44 K $6.00 K   100.00% 0.01%
WELLS FARGO & COMPANY/MN 05/13/2025 2.65 K $5.06 K   0.00% 0.01%
SRS CAPITAL ADVISORS, INC. 05/15/2025 2.50 K $4.78 K   100.00% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2025 2.43 K $4.65 K   100.00% 0.01%
FMR LLC 05/12/2025 80 $154   100.00% 0.00%
CITIGROUP INC 05/12/2025 0 $0   -100.00% 0.00%
ROYAL BANK OF CANADA 05/15/2025 0 $0   -100.00% 0.00%

Gain Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 36 institutional investors and hedge funds held shares of Gain Therapeutics, Inc.. The most heavily invested institutionals were:

DME Capital Management, LP: 566,130

JONES FINANCIAL COMPANIES LLLP: 427,700

GEODE CAPITAL MANAGEMENT, LLC: 282,211

VANGUARD GROUP INC: 254,990

MARSHALL WACE, LLP: 196,026

Gotham Asset Management, LLC: 153,984

9.80% of Gain Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 3.47 M shares in the last 24 months. This purchase volume represents approximately $5.83 M in transactions.